榴莲视频

Shalmali Pal

Shalmali Pal

Authors >

Shalmali Pal

Shalmali Pal joined 榴莲视频 in 2011 as the weekend editor. Shalmali started her career at the Times-Picayune newspaper in New Orleans, before moving to San Francisco, where she worked at several medical media and education outlets (Biomechanics, Auntminnie.com, Oncology News International). She holds a BA in English literature from the University of California Los Angeles and an MSJ from the Medill School of Journalism at Northwestern University. Shalmali also teaches yoga and indoor cycling.

Connect:

email image

Latest from Shalmali Pal

Illustration of an biopsy being taken from a breast with cancer

For Your Patients: The Crucial Role of the Biopsy in Breast Cancer

Biopsied tissue samples reveal key details about the cancer and its causes and effects

Immunotherapy for ROS1-Rearranged NSCLC

Chinese clinicians share real-world results; Jessica Jiyeong Lin, MD, talks TRIDENT-1

Illustration of the letter i on a piece of paper over a hand over a breast with cancer

Breast Cancer: The Basics of Diagnosis, Staging, and Treatment

Also, an overview of epidemiologic and geographic trends

Illustration of the letter i on a piece of paper over a hand over a breast with cancer

For Your Patients: Breast Cancer Basics

Risk factors, recognition, treatment, and beyond

Prasanth Ganesan, MD, DM, on Olanzapine for Whetting the Appetite During Chemotherapy

Study done in India confirms the antipsychotic is an effective appetite stimulant

Updates in EGFR-Mutated Oligometastatic NSCLC

Study finds survival boost, while experts weigh in on RT in local consolidative therapy and more

The Multidisciplinary Team: Bringing Their A-Game to Lung Cancer Care

Italian study looks at MDT challenges; Mara Antonoff, MD, on MDT, surgery, and stage III disease

Renato Martins, MD, MPH on Germline Testing in Lung Cancer

Will pathogenic germline variant data aid clinical decisions? Kara Maxwell, MD, discusses

Pre-Op Therapy and Lung Cancer Resection -- The Ideal Partners?

Jonathan D. Spicer, MD, PhD, on what pre-surgical immunotherapy has brought to the OR

IO Combo Therapy With Durvalumab for the Win in Advanced NSCLC?

COAST trial triumphed; did CCTG BR.34 score big? Natasha B. Leighl, MD, shares findings

5